Package

IHC Comprehensive Panel - ImmunoHistochemistry

₹13,500 ₹10,500

Save 22%

Also Known As

No data available

Test Parameters Included

Comprehensive Immunohistochemical Marker Panel - multiple protein antigen detections on FFPE tissue sections
Pathologist Histopathology Remark - interpreted by qualified pathologist with clinical correlation for tumor typing and diagnosis

Department

No data available

Methodology

ImmunoHistochemistry

Sample Required

Paraffin block / FFPE : * Sample Requirements (Tissue Block): * The test requires a Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Block. This is a specially prepared and preserved block of tissue from your previous biopsy or surgical procedure. * The tissue block must contain sufficient viable tumor tissue to allow for multiple thin sections to be cut and stained effectively for all antibodies in the panel. * Proper tissue fixation in 10% neutral buffered formalin is crucial. Inadequate fixation can compromise the quality of the proteins and potentially lead to inaccurate test results.

Preparation

Since this test is performed on a previously collected tissue sample, no direct patient preparation, such as fasting or avoiding over-the-counter medications, is required for the test itself. However, providing complete and accurate information is critical for accurate results. Here are the important preparation instructions and details needed: * Clinical History and Previous Reports: * Providing comprehensive clinical information and any previous pathology reports for reference is absolutely essential. This helps our pathologists select the most appropriate antibodies for the IHC panel and accurately interpret the results in the context of your unique medical situation. * Please include the specific reason for this IHC test (e.g., to confirm cancer, classify tumor type, determine primary source of metastatic cancer, or evaluate for specific therapy markers). * Provide any preliminary diagnosis or suspected type of cancer based on initial biopsy or imaging. * State the precise anatomical location from where the tissue sample (biopsy or surgical specimen) was originally obtained. * Summarize relevant findings from any prior imaging studies (CT, MRI, PET scans, etc.) that led to the biopsy. * Detail any history of previous treatments like chemotherapy, radiation, targeted therapy, or immunotherapy, as these can affect protein expression in tumor cells. * If the diagnosis is a metastatic tumor of unknown primary origin, any clinical suspicion regarding the possible original site (e.g., gastrointestinal, lung, breast) is highly valuable. * Sample Requirements (Tissue Block): * The test requires a Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Block. This is a specially prepared and preserved block of tissue from your previous biopsy or surgical procedure. * The tissue block must contain sufficient viable tumor tissue to allow for multiple thin sections to be cut and stained effectively for all antibodies in the panel. * Proper tissue fixation in 10% neutral buffered formalin is crucial. Inadequate fixation can compromise the quality of the proteins and potentially lead to inaccurate test results.

Schedule Report

7 Days

Emergency Report

Yes

Frequently Asked Questions

What is an IHC Comprehensive Panel?

It is a group of immunohistochemical stain tests performed on a tissue biopsy sample to identify specific proteins and markers that help determine the type, origin, and behavior of a tumor or disease.

What type of sample is required?

The test requires a Formalin-Fixed Paraffin-Embedded (FFPE) tissue block or cell block. The pathologist selects the appropriate IHC markers based on the clinical question and histology findings.

How long does the report take?

IHC panel reports are typically available within 3 to 5 working days, depending on the number of markers tested and complexity of interpretation.

Is fasting required before sample collection?

No, fasting is not required as this is a tissue-based test and not a blood test. The tissue sample is obtained through biopsy or surgical procedure.

What conditions is this panel used to diagnose?

IHC panels are widely used to classify carcinomas, lymphomas, sarcomas, and melanomas. They help distinguish primary tumors from metastases and guide targeted therapy decisions.

How are IHC results interpreted?

A trained pathologist evaluates staining patterns — including positive, negative, and borderline results — across all markers in the panel and provides a comprehensive diagnostic opinion correlated with H&E morphology and clinical context.

Test Description

IHC Comprehensive Panel - ImmunoHistochemistry TEST: IHC Comprehensive Panel for Diagnosis ALSO KNOWN AS: Immunohistochemistry Panel IHC Diagnostic...

Test Code

GDF6 IHC

Book This Test

Share this test

High-end laboratory & medical equipment.
Outstanding doctor team.
Personalized care & high-quality service.
Tailormade health screening packages.

T&C